Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nix-TB: BPaL Regimen for XDR-TB and MDR-TB
NCT02333799Phase 3Completed
- Sponsor
- TB Alliance
- Start
- Mar 2015
- Primary completion
- Jan 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Mar 2015; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02333799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333799.